456 related articles for article (PubMed ID: 29772457)
1. In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites.
Chavan BB; Tiwari S; G S; Nimbalkar RD; Garg P; R S; Talluri MVNK
J Pharm Biomed Anal; 2018 Aug; 157():59-74. PubMed ID: 29772457
[TBL] [Abstract][Full Text] [Related]
2. Metabolite characterization of ambrisentan, in in vitro and in vivo matrices by UHPLC/QTOF/MS/MS: Detection of glutathione conjugate of epoxide metabolite evidenced by in vitro GSH trapping assay.
Johnsi Rani P; Vishnuvardhan C; Nimbalkar RD; Garg P; Satheeshkumar N
J Pharm Biomed Anal; 2018 Jun; 155():320-328. PubMed ID: 29684813
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of fluvastatin metabolites in rats by UHPLC/Q-TOF/MS/MS and in silico toxicological screening of the metabolites.
Chavan BB; Kalariya PD; Nimbalkar RD; Garg P; Srinivas R; Kumar Talluri MVN
J Mass Spectrom; 2017 May; 52(5):296-314. PubMed ID: 28295913
[TBL] [Abstract][Full Text] [Related]
4. Time of flight mass spectrometry based in vitro and in vivo metabolite profiling of ribociclib and their toxicity prediction.
Sahu AK; Sengupta P
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jun; 1147():122142. PubMed ID: 32416594
[TBL] [Abstract][Full Text] [Related]
5. Rapid structural characterization of in vivo and in vitro metabolites of tinoridine using UHPLC-QTOF-MS/MS and in silico toxicological screening of its metabolites.
Kalariya PD; Patel PN; Kavya P; Sharma M; Garg P; Srinivas R; Talluri MV
J Mass Spectrom; 2015 Nov; 50(11):1222-33. PubMed ID: 26505767
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of vilazodone metabolites in rats and microsomes by ultrahigh-performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry.
Chavan BB; Kalariya PD; Tiwari S; Nimbalkar RD; Garg P; Srinivas R; Talluri MVNK
Rapid Commun Mass Spectrom; 2017 Dec; 31(23):1974-1984. PubMed ID: 28875544
[TBL] [Abstract][Full Text] [Related]
7. Identification and structural characterization of in vivo metabolites of balofloxacin in rat plasma, urine and feces samples using Q-TOF/LC/ESI/MS/MS : In silico toxicity studies.
Shankar G; Borkar RM; Udutha S; Anagoni SP; Srinivas R
J Pharm Biomed Anal; 2018 Sep; 159():200-211. PubMed ID: 29990887
[TBL] [Abstract][Full Text] [Related]
8. An available strategy based on accurate mass by ultra high performance liquid chromatography coupled to Fourier transform ion cyclotron resonance mass spectrometry technology to characterization of metabolic profile of palbociclib in rat urine, feces and bile.
Yao J; Jiang X; Liu Q; Yuan X; Feng T; Li K; Zhao L
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():37-46. PubMed ID: 31176268
[TBL] [Abstract][Full Text] [Related]
9. Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry.
Liu Y; Yao X; Song L; Liu H; Zhao Q; Jiang J; Ni G; Shi C; Ma X; Zhou H; Liu D; Hu P
J Pharm Biomed Anal; 2018 Aug; 157():189-200. PubMed ID: 29803910
[TBL] [Abstract][Full Text] [Related]
10. Comparative metabolism of Lappaconitine in rat and human liver microsomes and in vivo of rat using ultra high-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry.
Yang S; Zhang H; Beier RC; Sun F; Cao X; Shen J; Wang Z; Zhang S
J Pharm Biomed Anal; 2015 Jun; 110():1-11. PubMed ID: 25796978
[TBL] [Abstract][Full Text] [Related]
11. A systematic UHPLC-Q-TOF-MS/MS based analytical approach for characterization of flibanserin metabolites and establishment of biotransformation pathway.
Sharma MK; Sahu AK; Shah RP; Sengupta P
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():123011. PubMed ID: 34735976
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro metabolite profiling of nirmatrelvir using LC-Q-ToF-MS/MS along with the in silico approaches for prediction of metabolites and their toxicity.
Chaganti S; Kushwah BS; Velip L; Tiwari SS; Chilvery S; Godugu C; Samanthula G
Biomed Chromatogr; 2024 May; 38(5):e5849. PubMed ID: 38403275
[TBL] [Abstract][Full Text] [Related]
13. In vivo metabolic investigation of silodosin using UHPLC-QTOF-MS/MS and in silico toxicological screening of its metabolites.
Vishnuvardhan C; Baikadi S; Borkar RM; Srinivas R; Satheeshkumar N
J Mass Spectrom; 2016 Oct; 51(10):867-882. PubMed ID: 27747994
[TBL] [Abstract][Full Text] [Related]
14. In silico, in vitro and in vivo metabolite identification of brexpiprazole using ultra-high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Thakkar D; Kate AS
Rapid Commun Mass Spectrom; 2019 May; 33(11):1024-1035. PubMed ID: 30889624
[TBL] [Abstract][Full Text] [Related]
15. In vitroand in vivo investigation of metabolic fate of riociguat by HPLC-Q-TOF/MS/MS and in silico evaluation of the metabolites by ADMET predictor
Tiwari SS; Chavan BB; Kushwah BS; Yerra NV; Mukesh S; Sangamwar AT; Thaota JR; Talluri MVNK
J Pharm Biomed Anal; 2019 Feb; 164():326-336. PubMed ID: 30412806
[TBL] [Abstract][Full Text] [Related]
16. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Study of the Metabolites of Dietary Acacetin in Vivo and in Vitro Based on UHPLC-Q-TOF-MS/MS Analysis.
Yin J; Ma Y; Liang C; Gao J; Wang H; Zhang L
J Agric Food Chem; 2019 May; 67(19):5530-5543. PubMed ID: 31025561
[TBL] [Abstract][Full Text] [Related]
18. Identification of metabolites of vindoline in rats using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Zhang Y; Sun Y; Mu X; Yuan L; Wang Q; Zhang L
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():126-137. PubMed ID: 28609700
[TBL] [Abstract][Full Text] [Related]
19. Metabolic characterization of (±)-praeruptorin A in vitro and in vivo by high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry.
Song YL; Jing WH; Yan R; Wang YT
J Pharm Biomed Anal; 2014 Mar; 90():98-110. PubMed ID: 24342524
[TBL] [Abstract][Full Text] [Related]
20. In vivo metabolic investigation of moxifloxacin using liquid chromatography/electrospray ionization tandem mass spectrometry in combination with online hydrogen/deuterium exchange experiments.
Raju B; Ramesh M; Borkar RM; Srinivas R; Padiya R; Banerjee SK
Rapid Commun Mass Spectrom; 2012 Aug; 26(16):1817-31. PubMed ID: 22777784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
